开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Ioanna G. Alexandropoulou, Theodoros A. Parasidis, Theocharis G. Konstantinidis, Theodoros C. Constantinidis and Maria Panopoulou
Legionella bacteria are the causative agent of legionellosis, an infection mainly acquired through aspiration of contaminated water. Macrolides and flouroquinolones are the treatment of choice for legionellosis. The selection of these categories is mainly based on clinical experience. Especially erythromycin was the first line drug in the treatment of legionellosis, even though erythomycin resistant strains can easily be obtained in vitro. Flouroquinolones has been shown to succeed high intracellular inhibition of Legionella compared with erythromycin